As previously mentioned, there are several studies that have demonstrated the effectiveness and safety of anti-TNF-alpha drugs in the treatment of refractory BD uveitis, mainly patients treated with ADA and IFX [20,21,22,23,24,25,40,41,42]. This evidence concerns the gene TNF and uveitis.